GENDER IN RESISTANT HYPERTENSION: IMPACT ON CLINICAL MANIFESTATIONS, ASSOCIATED FACTORS AND HYPERTENSION TREATMENT

被引：0
|
作者：
Prejbisz, A. [1 ]
Gasowski, J. [2 ]
Klocek, M. [2 ]
Topor-Madry, R. [2 ,3 ]
Lesniak, W. [2 ]
Kabat, M. [1 ]
Czarnecka, D. [2 ]
Kawecka-Jaszcz, K. [2 ]
Narkiewicz, K. [4 ]
Januszewicz, A. [1 ]
机构：
[1] Inst Cardiol, Warsaw, Poland
[2] Jagiellonian Univ, Coll Med, Krakow, Poland
[3] Wroclaw Med Univ, Wroclaw, Poland
[4] Med Univ Gdansk, Gdansk, Poland
来源：
JOURNAL OF HYPERTENSION | 2016年 / 34卷
关键词：
D O I：
10.1097/01.hjh.0000491814.26971.48
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.10.10
引用
收藏
页码：E172 / E173
页数：2
相关论文
共 50 条
  • [41] Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension
    Shibata, Hirotaka
    Itoh, Hiroshi
    AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (05) : 514 - 523
  • [42] Impact of Environmental Factors on Hypertension and Associated Cardiovascular Disease
    Rios, Francisco J.
    Montezano, Augusto C.
    Camargo, Livia L.
    Touyz, Rhian M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2023, 39 (09) : 1229 - 1243
  • [43] Resistant Hypertension A Clinical Perspective
    Hannah-Shmouni, Fady
    Gubbi, Sriram
    Spence, J. David
    Stratakis, Constantine A.
    Koch, Christian A.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (04) : 811 - +
  • [44] The use of fixed dose combinations in the treatment of hypertension - resistant hypertension or patient resistant to treatment?
    Zieminski, Rafal
    Rogala, Wojciech
    Waszczuk, Aleksandra
    Dzida, Grzegorz
    ARTERIAL HYPERTENSION, 2015, 19 (03): : 140 - 144
  • [45] Impact of corticosteroid treatment and clinical risk factors in patients with alcohol-associated hepatitis and clinically significant portal hypertension
    Kujundzic, Petra Dinjar
    Milosevic, Marko
    Barisic-Jaman, Mislav
    Dohoczky, David
    Skurla, Viktoria
    Defar, Marta
    Cepic, Sara
    Pastrovic, Frane
    Grgurevic, Ivica
    JOURNAL OF HEPATOLOGY, 2024, 80 : S155 - S155
  • [46] PRAZOSIN IN THE TREATMENT OF RESISTANT HYPERTENSION ASSOCIATED TO RENAL-DISEASE
    CUESTA, V
    CANNATA, J
    HERRERA, J
    MAISUECHE, I
    PERAL, V
    REDONDO, C
    REVISTA CLINICA ESPANOLA, 1981, 161 (01): : 37 - 39
  • [47] Resistant hypertension: diagnosis, evaluation, and treatment a clinical consensus statement from the Thai hypertension society
    Chattranukulchai, Pairoj
    Roubsanthisuk, Weranuj
    Kunanon, Sirisawat
    Kotruchin, Praew
    Satirapoj, Bancha
    Wongpraparut, Nattawut
    Sunthornyothin, Sarat
    Sukonthasarn, Apichard
    HYPERTENSION RESEARCH, 2024, 47 (09) : 2447 - 2455
  • [48] Resistant Hypertension: Mechanisms and Treatment
    Andrew Y. Hwang
    Eric Dietrich
    Carl J. Pepine
    Steven M. Smith
    Current Hypertension Reports, 2017, 19
  • [49] Detection and Treatment of Resistant Hypertension
    Segura, Julian
    de la Sierra, Alejandro
    Ruilope, Luis M.
    CURRENT HYPERTENSION REPORTS, 2010, 12 (05) : 325 - 330
  • [50] Characterization and treatment of resistant hypertension
    Pisoni R.
    Ahmed M.I.
    Calhoun D.A.
    Current Cardiology Reports, 2009, 11 (6) : 407 - 413
12345